Telangana Government Reports Cases Of Mild Reactions Of People Taking COVID-19 Vaccines

After taking the Novel Coronavirus or COVID-19 vaccines, people in Telangana reported mild reactions.

On the 18th of January, the Telangana Health Department reported one or two cases of mild reactions during the mass COVID-19 vaccination drive.

Dr. Srinivas Rao, the State Director of Public Health and Family Welfare, said, “There are no reports of severe Adverse Event Following Immunization (AEFI) cases. However, a few mild reactions have been reported in one or two cases. They have been taken care of and kept under observation as a part of precautionary measures.”

Starting from the 16th of January, the Telangana vaccination drive administered COVID-19 vaccines to above 85 % of registered people at 140 centres on the 16th of January and 324 centres on the 18th and 19th of JanuaryCOVAXIN.

In order to increase the number of receivers of vaccines, the Telangana Health Department decided to increase the vaccination centres from 140 to 324 and added 180 new centres across Telangana.

Speaking about the given COVID-19 vaccines, Dr. Rao mentioned that out of the total vaccine stock, 95 % was that of Covishield and only 5 % were COVAXIN.

Mr. Rao said, “Telangana Government has got 20,000 Covaxin shots. As we have got more than 95 % of vaccines were Covishield and it has been rolled out across all the vaccination sites. We will use Covaxin in the coming days in accordance with the protocols laid by the Union Ministry of Health and Family Welfare. The consent of the beneficiary will be taken before administering the vaccine. All our vaccination centres are under the monitoring and supervision of the medical officers (sic.)”

The Drugs Controller General of India approved the Hyderabad based Bharat Biotech International Private Limited’s COVAXIN and the Serum Institute of India’s (SII) Covisheild to cure the deadly virus.

The Telangana government has vaccinated more than 18,000 beneficiaries till date.

Stay tuned for further updates.


Please enter your comment!
Please enter your name here